Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Enrique Alvarez

Concepts (306)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
46
2026
435
8.750
Why?
Multiple Sclerosis, Relapsing-Remitting
16
2026
66
3.920
Why?
Immunologic Factors
9
2026
244
3.230
Why?
Fingolimod Hydrochloride
6
2020
35
2.130
Why?
Natalizumab
5
2023
30
2.070
Why?
Multiple Sclerosis, Chronic Progressive
6
2023
24
1.990
Why?
Rituximab
7
2025
208
1.830
Why?
Immunosuppressive Agents
9
2024
829
1.250
Why?
Antibodies, Monoclonal, Humanized
6
2025
992
0.970
Why?
Agammaglobulinemia
2
2023
36
0.940
Why?
Dimethyl Fumarate
3
2020
9
0.940
Why?
Drug Substitution
2
2025
62
0.920
Why?
Oligoclonal Bands
3
2026
25
0.720
Why?
Neuromyelitis Optica
4
2020
135
0.670
Why?
Serum Sickness
1
2019
3
0.600
Why?
Magnetic Resonance Imaging
12
2026
3926
0.570
Why?
Adult
38
2026
41087
0.500
Why?
Medical Marijuana
1
2018
120
0.490
Why?
Middle Aged
37
2026
36619
0.480
Why?
Lymphocyte Depletion
3
2021
135
0.470
Why?
Antigens, CD20
3
2025
34
0.460
Why?
Antibodies, Monoclonal
5
2026
1512
0.460
Why?
Biomarkers
6
2026
4340
0.460
Why?
Pregnancy Complications
2
2018
609
0.460
Why?
Axons
2
2014
205
0.450
Why?
Humans
66
2026
146342
0.440
Why?
Marijuana Smoking
1
2018
249
0.440
Why?
Neurofilament Proteins
1
2014
83
0.410
Why?
Female
44
2026
79499
0.400
Why?
Clinical Trials as Topic
1
2018
1064
0.390
Why?
Anemia
1
2015
190
0.380
Why?
Chemokine CXCL13
1
2013
15
0.380
Why?
Recurrence
6
2024
1133
0.370
Why?
Male
40
2026
73396
0.350
Why?
Brain
9
2026
2991
0.320
Why?
Demyelinating Diseases
4
2026
78
0.320
Why?
T-Lymphocytes
3
2023
2012
0.290
Why?
Immunoglobulin G
4
2026
901
0.290
Why?
Muscle, Skeletal
6
2026
1818
0.270
Why?
Glatiramer Acetate
2
2019
11
0.270
Why?
Walking
4
2023
546
0.260
Why?
Injections, Subcutaneous
2
2025
170
0.260
Why?
Killer Cells, Natural
3
2021
481
0.260
Why?
Leukoencephalopathies
1
2026
23
0.240
Why?
Neuroimaging
2
2026
307
0.240
Why?
Fatigue
3
2026
363
0.230
Why?
B-Lymphocytes
3
2023
887
0.230
Why?
Patient Preference
2
2026
226
0.220
Why?
Neurons
4
2026
1668
0.220
Why?
Chromosomes, Human, X
1
2005
76
0.220
Why?
Treatment Outcome
10
2026
11821
0.220
Why?
Remyelination
1
2025
15
0.220
Why?
Administration, Intravenous
1
2025
172
0.220
Why?
Multigene Family
1
2005
210
0.210
Why?
Decision Making
2
2026
993
0.210
Why?
Immunoglobulin A
1
2026
205
0.210
Why?
Retrospective Studies
10
2025
17438
0.210
Why?
White Matter
1
2026
169
0.200
Why?
Isometric Contraction
1
2026
200
0.200
Why?
Central Nervous System
1
2026
278
0.200
Why?
Atrophy
2
2021
199
0.200
Why?
Mammary Neoplasms, Experimental
1
2003
61
0.190
Why?
Neuroprotection
1
2023
46
0.190
Why?
Diphosphonates
1
2003
68
0.190
Why?
Bone Resorption
1
2003
81
0.190
Why?
Alemtuzumab
1
2023
15
0.190
Why?
Nitro Compounds
1
2023
8
0.190
Why?
Myelin Sheath
1
2025
166
0.190
Why?
Disease Progression
7
2026
2867
0.180
Why?
Quality of Life
5
2026
3200
0.180
Why?
Cellular Senescence
1
2025
225
0.180
Why?
Thiazoles
1
2023
139
0.180
Why?
Microglia
1
2025
289
0.180
Why?
Double-Blind Method
6
2026
2070
0.180
Why?
Gadolinium
2
2022
78
0.180
Why?
Interoception
1
2021
3
0.170
Why?
Enzyme-Linked Immunosorbent Assay
3
2026
846
0.170
Why?
Nerve Tissue Proteins
1
2005
597
0.170
Why?
Diagnostic Self Evaluation
1
2021
24
0.170
Why?
Drug Costs
1
2023
116
0.170
Why?
Neuroblastoma
1
2023
177
0.170
Why?
Stair Climbing
1
2021
6
0.170
Why?
Crotonates
3
2026
7
0.170
Why?
Inflammation
1
2013
2919
0.170
Why?
Toluidines
3
2026
10
0.170
Why?
Hydroxybutyrates
3
2026
15
0.170
Why?
Resistance Training
1
2024
186
0.160
Why?
Gene Expression Regulation, Developmental
1
2005
902
0.160
Why?
Lymphopenia
1
2020
62
0.160
Why?
Young Adult
7
2026
14330
0.160
Why?
Interferon-gamma
1
2023
781
0.150
Why?
Hippocampus
3
2002
989
0.150
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
156
0.150
Why?
Personality
1
2021
132
0.150
Why?
Torso
1
2020
36
0.150
Why?
Cancer Vaccines
1
2021
161
0.150
Why?
Excitatory Amino Acid Antagonists
2
2002
108
0.150
Why?
Neutropenia
1
2020
153
0.150
Why?
Nitriles
3
2026
212
0.150
Why?
Transcutaneous Electric Nerve Stimulation
1
2019
23
0.150
Why?
Muscle Strength
2
2024
340
0.150
Why?
Transforming Growth Factor beta
2
2017
467
0.150
Why?
Disease Management
1
2023
651
0.150
Why?
Receptors, Glutamate
1
1999
27
0.140
Why?
Sodium Glutamate
1
1999
12
0.140
Why?
Pelvis
1
2020
129
0.140
Why?
Avoidance Learning
1
1999
64
0.140
Why?
Phosphodiesterase Inhibitors
1
2018
73
0.140
Why?
Nerve Net
1
2021
286
0.140
Why?
Muscle Spasticity
1
2018
63
0.130
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
266
0.130
Why?
Cognition
1
2026
1292
0.130
Why?
Dendritic Cells
1
2021
509
0.130
Why?
Electric Stimulation Therapy
1
2018
63
0.130
Why?
Immunotherapy, Adoptive
1
2021
356
0.130
Why?
Reaction Time
1
1999
438
0.120
Why?
Interferon beta-1a
1
2016
12
0.120
Why?
Gait
1
2020
322
0.120
Why?
Psychomotor Performance
1
2019
329
0.120
Why?
T-Lymphocyte Subsets
1
2019
416
0.120
Why?
Postural Balance
1
2019
249
0.120
Why?
CD40 Antigens
1
2016
69
0.120
Why?
Follow-Up Studies
3
2020
5439
0.120
Why?
Lymphocyte Activation
2
2019
1137
0.120
Why?
Continuous Positive Airway Pressure
1
2017
91
0.120
Why?
Transcription Factor RelA
1
2016
93
0.120
Why?
Drug Administration Schedule
1
2018
790
0.120
Why?
Patient Care Planning
1
2017
170
0.120
Why?
Mycophenolic Acid
1
2016
117
0.120
Why?
Prospective Studies
2
2025
8123
0.110
Why?
Movement
3
2023
290
0.110
Why?
Contrast Media
1
2018
493
0.110
Why?
Physicians
1
2023
955
0.110
Why?
Survival Analysis
1
2018
1378
0.110
Why?
MAP Kinase Signaling System
1
2016
307
0.110
Why?
Postpartum Period
1
2017
377
0.100
Why?
Monocytes
1
2017
538
0.100
Why?
Melanoma
1
2021
765
0.100
Why?
Proteomics
3
2026
1203
0.100
Why?
Disability Evaluation
4
2018
297
0.100
Why?
Pyridines
1
2018
610
0.100
Why?
Skin Neoplasms
1
2021
806
0.100
Why?
Patient Participation
1
2017
457
0.100
Why?
Pain
1
2018
790
0.090
Why?
Sleep Apnea, Obstructive
1
2017
300
0.090
Why?
Aged
7
2026
26432
0.090
Why?
Rats
5
2005
5586
0.090
Why?
Dopamine
2
2005
295
0.090
Why?
Adolescent
5
2026
22557
0.090
Why?
Leukoencephalopathy, Progressive Multifocal
1
2011
37
0.080
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
96
0.080
Why?
Time Factors
2
2021
7109
0.080
Why?
Membrane Proteins
1
2017
1130
0.080
Why?
Antigen-Presenting Cells
1
2011
161
0.080
Why?
Infusions, Intravenous
2
2023
432
0.080
Why?
Health Personnel
1
2017
754
0.080
Why?
Hypoxia
1
2017
1211
0.070
Why?
Leukocytes
1
2011
301
0.070
Why?
Lymphocytes
1
2011
379
0.070
Why?
Animals
8
2025
38107
0.070
Why?
Cross-Sectional Studies
4
2026
5899
0.070
Why?
Neoplasms
1
2024
2954
0.070
Why?
Pregnancy
2
2018
7230
0.070
Why?
Case-Control Studies
2
2013
3647
0.070
Why?
Spinal Cord
2
2012
378
0.070
Why?
MicroRNAs
1
2013
699
0.060
Why?
Biomechanical Phenomena
2
2021
874
0.060
Why?
Rats, Inbred F344
2
2003
266
0.060
Why?
Microinjections
3
2002
92
0.060
Why?
Incidental Findings
1
2026
81
0.060
Why?
Haplorhini
1
2005
51
0.060
Why?
Glycosylation
1
2026
177
0.060
Why?
Sequence Homology, Nucleic Acid
1
2005
157
0.060
Why?
Immunologic Memory
2
2019
369
0.060
Why?
Protein Aggregates
1
2026
87
0.060
Why?
Chemokine CCL11
1
2025
25
0.060
Why?
Cohort Studies
3
2026
6077
0.050
Why?
Organ Specificity
1
2005
307
0.050
Why?
Pilot Projects
2
2021
1888
0.050
Why?
Cytoplasm
1
2005
253
0.050
Why?
Immunoglobulin M
1
2026
284
0.050
Why?
Proteasome Endopeptidase Complex
1
2005
155
0.050
Why?
Species Specificity
1
2005
543
0.050
Why?
Risk Factors
1
2018
10921
0.050
Why?
Electric Stimulation
2
2021
273
0.050
Why?
Parathyroid Hormone-Related Protein
1
2003
25
0.050
Why?
Tyrosine 3-Monooxygenase
1
2004
72
0.050
Why?
Osteolysis
1
2003
17
0.050
Why?
Models, Biological
1
2011
1761
0.050
Why?
Nerve Growth Factors
1
2004
79
0.050
Why?
Electromyography
1
2026
428
0.050
Why?
Oligonucleotide Array Sequence Analysis
1
2005
752
0.050
Why?
Cytokines
1
2011
2081
0.050
Why?
Pluripotent Stem Cells
1
2004
78
0.050
Why?
Depression
2
2026
1575
0.050
Why?
Clinical Trials, Phase IV as Topic
1
2022
2
0.050
Why?
Mice
3
2025
18297
0.050
Why?
Aging
2
2025
1996
0.050
Why?
Oligodendroglia
1
2025
198
0.050
Why?
Kynurenic Acid
1
2002
18
0.050
Why?
Intermediate Filaments
1
2022
16
0.050
Why?
Arm
1
2023
111
0.040
Why?
Histamine
1
1982
52
0.040
Why?
Cell Nucleus
1
2005
584
0.040
Why?
Cell Division
1
2003
736
0.040
Why?
Maze Learning
1
2002
106
0.040
Why?
Arthritis, Rheumatoid
1
2011
1185
0.040
Why?
Patient Outcome Assessment
1
2023
129
0.040
Why?
Base Sequence
1
2005
2123
0.040
Why?
Behavior, Animal
2
2002
531
0.040
Why?
Regional Blood Flow
1
2024
507
0.040
Why?
Heart
1
2005
626
0.040
Why?
MART-1 Antigen
1
2021
9
0.040
Why?
Gray Matter
1
2022
96
0.040
Why?
Molecular Sequence Data
1
2005
2838
0.040
Why?
Neoplasm Metastasis
1
2003
693
0.040
Why?
Research Report
1
2021
89
0.040
Why?
Multicenter Studies as Topic
1
2022
417
0.040
Why?
Cell Survival
1
2003
1105
0.040
Why?
Mobility Limitation
1
2020
68
0.040
Why?
Receptors, N-Methyl-D-Aspartate
1
2002
233
0.040
Why?
Long-Term Potentiation
1
2002
206
0.040
Why?
Complement System Proteins
1
2023
326
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
344
0.040
Why?
Feasibility Studies
1
2024
1135
0.040
Why?
Antibodies, Viral
1
2023
689
0.040
Why?
Lymphocyte Count
1
2019
167
0.040
Why?
Maintenance Chemotherapy
1
2019
41
0.040
Why?
Indolizines
1
2018
13
0.040
Why?
Adaptation, Physiological
1
2023
568
0.030
Why?
Motor Skills
1
2019
103
0.030
Why?
Induction Chemotherapy
1
2019
87
0.030
Why?
Gene Expression Profiling
1
2005
1792
0.030
Why?
Hand
1
2019
157
0.030
Why?
Diffusion Tensor Imaging
1
2018
83
0.030
Why?
Combined Modality Therapy
1
2021
1271
0.030
Why?
Myeloid Cells
1
2019
149
0.030
Why?
Leg
1
2019
246
0.030
Why?
Homeostasis
1
2021
646
0.030
Why?
Headache
1
2018
150
0.030
Why?
Organ Size
1
2018
465
0.030
Why?
Tumor Escape
1
2017
50
0.030
Why?
Neoplasm Staging
1
2021
1488
0.030
Why?
Internet
1
2021
660
0.030
Why?
Macrophages
1
2025
1532
0.030
Why?
Knee Joint
1
2021
453
0.030
Why?
Liver
1
2005
1864
0.030
Why?
Cytotoxicity, Immunologic
1
2017
224
0.030
Why?
Memory
1
1999
298
0.030
Why?
Gastrointestinal Diseases
1
2018
220
0.030
Why?
Cluster Analysis
1
2017
496
0.030
Why?
Cell Differentiation
1
2004
1982
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
174
0.030
Why?
T-Lymphocytes, Regulatory
1
2019
415
0.030
Why?
Randomized Controlled Trials as Topic
1
2022
1763
0.030
Why?
Cell Line, Tumor
1
2003
3545
0.030
Why?
Risk
1
2017
920
0.030
Why?
Pyrazoles
1
2018
517
0.030
Why?
Apoptosis
1
2023
2439
0.030
Why?
Focus Groups
1
2017
588
0.030
Why?
Clinical Decision-Making
1
2017
365
0.020
Why?
Mice, Inbred C57BL
1
2025
6034
0.020
Why?
Drug Therapy, Combination
1
2016
1036
0.020
Why?
Incidence
1
2020
2936
0.020
Why?
Prognosis
1
2022
4351
0.020
Why?
Socioeconomic Factors
1
2017
1327
0.020
Why?
Genetic Markers
1
2013
340
0.020
Why?
Antineoplastic Agents
1
2003
2219
0.020
Why?
Phosphorylation
1
2016
1724
0.020
Why?
Patient-Centered Care
1
2017
553
0.020
Why?
Pandemics
1
2020
1707
0.020
Why?
Statistics, Nonparametric
1
2012
426
0.020
Why?
Down-Regulation
1
2013
614
0.020
Why?
Infant, Newborn
1
2023
6460
0.020
Why?
Pain Measurement
1
2012
573
0.020
Why?
Electronic Health Records
1
2017
1210
0.020
Why?
Pain Management
1
2012
421
0.020
Why?
Predictive Value of Tests
1
2013
2113
0.020
Why?
Aged, 80 and over
1
2017
8391
0.010
Why?
Severity of Illness Index
1
2012
2921
0.010
Why?
Glial Cell Line-Derived Neurotrophic Factor
1
2004
17
0.010
Why?
Cell Shape
1
2004
56
0.010
Why?
Mesencephalon
1
2004
65
0.010
Why?
Culture Media, Conditioned
1
2004
112
0.010
Why?
Stromal Cells
1
2004
123
0.010
Why?
Coculture Techniques
1
2004
245
0.010
Why?
Grooming
1
1982
9
0.010
Why?
Stem Cell Transplantation
1
2004
190
0.010
Why?
Spermine
1
2002
29
0.010
Why?
Rats, Inbred Strains
1
1982
316
0.010
Why?
Corpus Striatum
1
2004
181
0.010
Why?
Astrocytes
1
2004
229
0.010
Why?
Oligonucleotides, Antisense
1
2002
122
0.010
Why?
Excitatory Postsynaptic Potentials
1
2002
119
0.010
Why?
Locomotion
1
1982
102
0.010
Why?
Catheterization
1
2002
179
0.010
Why?
Calcium Channel Blockers
1
2002
165
0.010
Why?
United States
1
2018
16136
0.010
Why?
In Vitro Techniques
1
2002
1041
0.010
Why?
Blotting, Western
1
2002
1177
0.010
Why?
Action Potentials
1
2002
500
0.010
Why?
Gene Expression
1
2002
1463
0.010
Why?
Parkinson Disease
1
2004
614
0.010
Why?
Cell Proliferation
1
2004
2502
0.010
Why?
Cells, Cultured
1
2004
4118
0.010
Why?
Phenotype
1
2004
3206
0.010
Why?
Alvarez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)